Results 211 to 220 of about 1,979,548 (395)

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

A New ICD-10 Code for Hemorrhagic Myocardial Infarction. [PDF]

open access: yesJACC Adv
Kalra A, Kumbhani DJ, Dharmakumar R.
europepmc   +1 more source

Fully Automated 2D and 3D Convolutional Neural Networks Pipeline for Video Segmentation and Myocardial Infarction Detection in Echocardiography

open access: green, 2021
Oumaima Hamila   +6 more
openalex   +1 more source

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy